TD Asset Management Inc. raised its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.6% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 223,023 shares of the medical equipment provider’s stock after purchasing an additional 11,802 shares during the quarter. TD Asset Management Inc.’s holdings in Intuitive Surgical were worth $127,252,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of ISRG. Stone House Investment Management LLC bought a new position in shares of Intuitive Surgical during the first quarter worth about $31,000. Laurel Wealth Advisors LLC bought a new stake in Intuitive Surgical in the fourth quarter worth approximately $32,000. Athena Capital Advisors LLC bought a new stake in Intuitive Surgical in the fourth quarter worth approximately $33,000. Financial Advantage Inc. bought a new stake in Intuitive Surgical in the fourth quarter worth approximately $36,000. Finally, Harvest Group Wealth Management LLC bought a new stake in Intuitive Surgical in the first quarter worth approximately $44,000. Hedge funds and other institutional investors own 84.85% of the company’s stock.

Shares of NASDAQ:ISRG traded up $3.68 during mid-day trading on Tuesday, hitting $486.90. 10,919 shares of the company traded hands, compared to its average volume of 774,914. The stock has a market cap of $56.59 billion, a price-to-earnings ratio of 51.36, a PEG ratio of 4.28 and a beta of 1.02. Intuitive Surgical, Inc. has a 12-month low of $430.24 and a 12-month high of $589.32.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, April 18th. The medical equipment provider reported $2.61 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $2.70 by ($0.09). The company had revenue of $974.00 million for the quarter, compared to analysts’ expectations of $975.27 million. Intuitive Surgical had a net margin of 29.78% and a return on equity of 17.33%. The firm’s quarterly revenue was up 14.9% on a year-over-year basis. During the same period in the previous year, the firm earned $2.44 EPS. As a group, analysts anticipate that Intuitive Surgical, Inc. will post 9.4 earnings per share for the current year.

In other Intuitive Surgical news, CEO Gary S. Guthart sold 22,636 shares of the business’s stock in a transaction on Monday, May 6th. The stock was sold at an average price of $501.48, for a total value of $11,351,501.28. Following the transaction, the chief executive officer now owns 386,866 shares of the company’s stock, valued at $194,005,561.68. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, VP Jamie Samath sold 2,236 shares of the business’s stock in a transaction on Thursday, February 21st. The stock was sold at an average price of $547.36, for a total value of $1,223,896.96. Following the completion of the transaction, the vice president now directly owns 636 shares in the company, valued at approximately $348,120.96. The disclosure for this sale can be found here. In the last three months, insiders sold 32,265 shares of company stock worth $16,439,238. Insiders own 1.70% of the company’s stock.

A number of equities research analysts have weighed in on the company. Citigroup lowered their target price on Intuitive Surgical from $611.00 to $575.00 and set a “buy” rating for the company in a report on Tuesday, May 14th. Zacks Investment Research downgraded Intuitive Surgical from a “hold” rating to a “sell” rating in a report on Wednesday, April 24th. Raymond James lowered their target price on Intuitive Surgical from $630.00 to $610.00 and set an “outperform” rating for the company in a report on Monday, April 22nd. Canaccord Genuity reiterated a “buy” rating and issued a $575.00 target price (down from $610.00) on shares of Intuitive Surgical in a report on Monday, April 22nd. Finally, BTIG Research reiterated a “hold” rating on shares of Intuitive Surgical in a report on Sunday, April 21st. Two analysts have rated the stock with a sell rating, four have given a hold rating and fourteen have assigned a buy rating to the company’s stock. Intuitive Surgical presently has a consensus rating of “Buy” and an average target price of $576.82.

COPYRIGHT VIOLATION NOTICE: “TD Asset Management Inc. Boosts Holdings in Intuitive Surgical, Inc. (ISRG)” was reported by Watch List News and is owned by of Watch List News. If you are viewing this story on another publication, it was illegally copied and republished in violation of U.S. & international copyright & trademark law. The legal version of this story can be viewed at https://www.watchlistnews.com/td-asset-management-inc-boosts-holdings-in-intuitive-surgical-inc-isrg/3017866.html.

Intuitive Surgical Profile

Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.

Recommended Story: Net Income

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.